Arrowhead Pharmaceuticals (ARWR) Institutional Ownership

$13.82 +0.02 (+0.14%)

Closing price 03/28/2025 04:00 PM Eastern

Extended Trading

$13.82 +0.00 (+0.04%)

As of 03/28/2025 07:47 PM Eastern

Compare

Current Institutional Ownership Percentage: 62.61%
Number of Institutional Buyers (last 12 months): 143
Total Institutional Inflows (last 12 months): $541.25M

Number of Institutional Sellers (last 12 months): 90
Total Institutional Outflows (last 12 months): $149.80M

Get ARWR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Arrowhead Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ARWR Institutional Buying and Selling by Quarter

Remove Ads

Arrowhead Pharmaceuticals Major Shareholders & Ownership History

Export to Excel

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/24/2025	Wellington Management Group LLP	55,396	$1.04M	0.0%	-10.5%	0.040%
3/18/2025	California State Teachers Retirement System	105,154	$1.98M	0.0%	-1.1%	0.077%
2/20/2025	Mackenzie Financial Corp	7,299	$137K	0.0%	N/A	0.006%
2/19/2025	GF Fund Management CO. LTD.	2,613	$49K	0.0%	N/A	0.002%
2/18/2025	Neo Ivy Capital Management	16,920	$318K	0.1%	N/A	0.013%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	2,010,129	$37.79M	0.0%	-6.7%	1.607%
2/17/2025	Woodline Partners LP	840,174	$15.80M	0.1%	-3.0%	0.672%
2/17/2025	Squarepoint Ops LLC	86,044	$1.62M	0.0%	-55.6%	0.069%
2/17/2025	Two Sigma Advisers LP	430,700	$8.10M	0.0%	+330.7%	0.344%
2/17/2025	Two Sigma Investments LP	794,373	$14.93M	0.0%	+281.3%	0.635%
Get the Latest News and Ratings for ARWR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Arrowhead Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
2/17/2025	Tidal Investments LLC	21,249	$399K	0.0%	-4.8%	0.017%
2/17/2025	Tema Etfs LLC	61,503	$1.16M	0.5%	N/A	0.049%
2/17/2025	Silvercrest Asset Management Group LLC	280,511	$5.27M	0.0%	+24.7%	0.224%
2/17/2025	Sphera Funds Management LTD.	197,550	$3.71M	0.7%	N/A	0.158%
2/17/2025	Rafferty Asset Management LLC	138,377	$2.60M	0.0%	-23.5%	0.111%
2/17/2025	ProShare Advisors LLC	45,330	$852K	0.0%	+28.3%	0.036%
2/17/2025	Nomura Holdings Inc.	16,466	$310K	0.0%	+54.1%	0.013%
2/17/2025	Nuveen Asset Management LLC	332,749	$6.26M	0.0%	-0.8%	0.266%
2/17/2025	Millennium Management LLC	914,550	$17.19M	0.0%	+41.7%	0.731%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	242,702	$4.56M	0.0%	+15.9%	0.194%
2/17/2025	Integral Health Asset Management LLC	275,000	$5.17M	0.4%	N/A	0.220%
2/17/2025	Hudson Bay Capital Management LP	175,000	$3.29M	0.0%	-20.5%	0.140%
2/17/2025	Farallon Capital Management LLC	628,800	$11.82M	0.1%	N/A	0.503%
2/17/2025	Deutsche Bank AG	258,964	$4.87M	0.0%	+17.0%	0.207%
2/17/2025	Brevan Howard Capital Management LP	34,556	$650K	0.0%	+232.2%	0.028%
2/17/2025	Captrust Financial Advisors	17,074	$321K	0.0%	+13.5%	0.014%
2/17/2025	Balyasny Asset Management L.P.	372,749	$7.01M	0.0%	+266.0%	0.298%
2/17/2025	Bank of America Corp DE	575,974	$10.83M	0.0%	-0.5%	0.461%
2/17/2025	BNP Paribas Financial Markets	88,029	$1.66M	0.0%	+59.5%	0.070%
2/17/2025	Ameriprise Financial Inc.	224,988	$4.23M	0.0%	+2.6%	0.180%
2/17/2025	Algert Global LLC	27,377	$515K	0.0%	-26.0%	0.022%
2/14/2025	Comerica Bank	35,921	$675K	0.0%	-5.9%	0.029%
2/14/2025	Schonfeld Strategic Advisors LLC	632,214	$11.89M	0.1%	+63.1%	0.505%
2/14/2025	Northern Trust Corp	1,484,419	$27.91M	0.0%	+11.4%	1.187%
2/14/2025	The Manufacturers Life Insurance Company	138,294	$2.60M	0.0%	-2.6%	0.111%
2/14/2025	Tudor Investment Corp ET AL	66,573	$1.25M	0.0%	+6.6%	0.053%
2/14/2025	Aquatic Capital Management LLC	169,394	$3.19M	0.1%	+80.9%	0.135%
2/14/2025	Voya Investment Management LLC	53,793	$1.01M	0.0%	-82.1%	0.043%
2/14/2025	T. Rowe Price Investment Management Inc.	2,507,296	$47.14M	0.0%	-29.9%	2.005%
2/14/2025	Price T Rowe Associates Inc. MD	75,858	$1.43M	0.0%	-0.8%	0.061%
Your Wealth is Under Attack (Ad) Please don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your free gift, and see how Trump's victory could spark major gains for gold. Click here now to see how to stop them in their tracks!
2/14/2025	Dark Forest Capital Management LP	172,623	$3.25M	0.5%	+82.6%	0.138%
2/14/2025	Slate Path Capital LP	5,232,000	$98.36M	1.8%	+7.1%	4.183%
2/14/2025	Avoro Capital Advisors LLC	11,111,111	$208.89M	3.0%	+25.0%	8.884%
2/14/2025	State of Tennessee Department of Treasury	30,748	$578K	0.0%	-2.7%	0.025%
2/14/2025	Tower Research Capital LLC TRC	37,792	$710K	0.0%	+314.4%	0.030%
2/14/2025	MetLife Investment Management LLC	141,011	$2.65M	0.0%	+7.6%	0.113%
2/14/2025	Dimensional Fund Advisors LP	35,666	$671K	0.0%	-70.7%	0.029%
2/14/2025	Capital International Investors	126,230	$2.37M	0.0%	-50.7%	0.100%
2/14/2025	Altium Capital Management LLC	230,257	$4.33M	1.2%	-35.1%	0.183%
2/13/2025	CANADA LIFE ASSURANCE Co	100,589	$1.89M	0.0%	-4.8%	0.080%
2/13/2025	Marshall Wace LLP	86,633	$1.63M	0.0%	N/A	0.069%
2/13/2025	Affinity Asset Advisors LLC	300,000	$5.64M	0.8%	-7.7%	0.240%
2/13/2025	Jump Financial LLC	140,959	$2.65M	0.1%	-9.5%	0.113%
2/13/2025	Guggenheim Capital LLC	46,408	$872K	0.0%	-29.1%	0.037%
2/13/2025	Barclays PLC	312,560	$5.88M	0.0%	+13.0%	0.250%
2/13/2025	Summit Investment Advisors Inc.	37,994	$714K	0.6%	+2.2%	0.030%
2/13/2025	CenterBook Partners LP	350,473	$6.59M	0.4%	-11.2%	0.280%
2/13/2025	Raymond James Financial Inc.	34,633	$651K	0.0%	N/A	0.028%
2/13/2025	Legal & General Group Plc	245,272	$4.61M	0.0%	-3.7%	0.196%
2/13/2025	Invesco Ltd.	176,235	$3.31M	0.0%	-27.4%	0.141%
2/13/2025	ADAR1 Capital Management LLC	12,900	$243K	0.0%	+10.2%	0.010%
2/13/2025	Bank of Montreal Can	15,018	$282K	0.0%	+13.3%	0.012%
2/13/2025	FMR LLC	5,101,083	$95.90M	0.0%	-15.9%	4.079%
2/13/2025	Federated Hermes Inc.	4,875	$92K	0.0%	-14.1%	0.004%
2/13/2025	Russell Investments Group Ltd.	183,289	$3.45M	0.0%	-41.9%	0.147%
2/13/2025	Dynamic Technology Lab Private Ltd	19,142	$360K	0.1%	N/A	0.015%
2/13/2025	Wells Fargo & Company MN	62,886	$1.18M	0.0%	+43.1%	0.050%
2/13/2025	Resona Asset Management Co. Ltd.	22,292	$420K	0.0%	N/A	0.018%
2/12/2025	Trexquant Investment LP	100,798	$1.90M	0.0%	-46.0%	0.081%
2/12/2025	Headlands Technologies LLC	20,749	$390K	0.0%	+15.3%	0.017%
2/12/2025	Geode Capital Management LLC	2,954,947	$55.57M	0.0%	-0.3%	2.363%
2/12/2025	Wellington Management Group LLP	55,396	$1.04M	0.0%	-10.5%	0.044%
2/12/2025	California Public Employees Retirement System	140,150	$2.64M	0.0%	-8.9%	0.112%
2/12/2025	Schroder Investment Management Group	206,070	$3.84M	0.0%	-1.2%	0.165%
2/12/2025	Norges Bank	2,054,364	$38.62M	0.0%	N/A	1.643%
2/12/2025	NEOS Investment Management LLC	61,503	$1.16M	0.0%	-6.1%	0.049%
2/12/2025	Mitsubishi UFJ Asset Management Co. Ltd.	13,281	$263K	0.0%	+23.8%	0.011%
2/11/2025	EntryPoint Capital LLC	12,375	$233K	0.1%	N/A	0.010%
2/11/2025	Prudential Financial Inc.	12,285	$228K	0.0%	-7.2%	0.010%
2/11/2025	Corebridge Financial Inc.	199,154	$3.74M	0.0%	-5.1%	0.159%
2/11/2025	Vanguard Group Inc.	12,184,289	$229.07M	0.0%	-0.4%	9.742%
2/11/2025	Fox Run Management L.L.C.	52,342	$984K	0.2%	-6.6%	0.042%
2/11/2025	KLP Kapitalforvaltning AS	23,100	$434K	0.0%	N/A	0.018%
2/11/2025	Virtu Financial LLC	20,266	$381K	0.0%	N/A	0.016%
2/11/2025	Magnetar Financial LLC	14,367	$270K	0.0%	N/A	0.011%
2/11/2025	Teacher Retirement System of Texas	33,154	$623K	0.0%	+18.3%	0.027%
2/11/2025	Privium Fund Management B.V.	380,586	$7.16M	1.6%	+14.2%	0.304%
2/11/2025	Xponance Inc.	17,400	$327K	0.0%	+4.5%	0.014%
2/11/2025	Intech Investment Management LLC	88,661	$1.67M	0.0%	+160.4%	0.071%
2/10/2025	Cibc World Markets Corp	11,172	$210K	0.0%	N/A	0.009%
Musk’s real agenda in D.C. (Ad) In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America… Here’s the full story.
2/10/2025	Envestnet Portfolio Solutions Inc.	10,080	$190K	0.0%	N/A	0.008%
2/10/2025	Swiss National Bank	220,000	$4.14M	0.0%	+0.8%	0.176%
2/7/2025	HighTower Advisors LLC	75,056	$1.41M	0.0%	-39.2%	0.060%
2/7/2025	Wealthfront Advisers LLC	109,566	$2.06M	0.0%	N/A	0.088%
2/7/2025	King Luther Capital Management Corp	76,965	$1.45M	0.0%	N/A	0.062%
2/7/2025	Amundi	5,360	$106K	0.0%	-21.1%	0.004%
2/7/2025	PNC Financial Services Group Inc.	3,485	$66K	0.0%	-26.8%	0.003%
2/7/2025	Edgestream Partners L.P.	120,411	$2.26M	0.1%	N/A	0.096%
2/6/2025	Raymond James Financial Inc.	34,633	$651K	0.0%	N/A	0.028%
2/6/2025	Victory Capital Management Inc.	22,737	$427K	0.0%	-42.1%	0.018%

(Data available from 1/1/2016 forward)

Remove Ads

ARWR Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ARWR shares?: During the previous two years, 262 institutional investors and hedge funds held shares of Arrowhead Pharmaceuticals. The most heavily invested institutionals were Vanguard Group Inc. ($229.07M), Avoro Capital Advisors LLC ($208.89M), State Street Corp ($123.08M), Slate Path Capital LP ($98.36M), FMR LLC ($95.90M), Geode Capital Management LLC ($55.57M), and Credit Suisse AG ($51.01M).Learn more on ARWR's institutional investors.
What percentage of Arrowhead Pharmaceuticals stock is owned by institutional investors?: 62.61% of Arrowhead Pharmaceuticals stock is owned by institutional investors. Learn more on ARWR's institutional investor holdings.
Which institutional investors have been buying Arrowhead Pharmaceuticals stock?: Of the 215 institutional investors that purchased Arrowhead Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Avoro Capital Advisors LLC ($10.55M), Norges Bank ($3.38M), Vanguard Group Inc. ($1.73M), FMR LLC ($1.58M), Assenagon Asset Management S.A. ($1.01M), Farallon Capital Management LLC ($628.80K), and Goldman Sachs Group Inc. ($613.07K).

How much institutional buying is happening at Arrowhead Pharmaceuticals?: Institutional investors have bought a total of 31,494,277 shares in the last 24 months. This purchase volume represents approximately $804.13M in transactions.
Which Arrowhead Pharmaceuticals major shareholders have been selling company stock?: Of the 142 institutional investors that sold Arrowhead Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: FMR LLC ($1.71M), T. Rowe Price Investment Management Inc. ($1.07M), Fiera Capital Corp ($1.03M), Assenagon Asset Management S.A. ($955.74K), Capital International Investors ($928.10K), Principal Financial Group Inc. ($361.30K), and Avidity Partners Management LP ($349.90K).
How much institutional selling is happening at Arrowhead Pharmaceuticals?: Institutional investors have sold a total of 11,667,762 shares in the last 24 months. This volume of shares sold represents approximately $279.63M in transactions.

Related Companies

This page (NASDAQ:ARWR) was last updated on 3/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Arrowhead Pharmaceuticals (ARWR) Institutional Ownership

ARWR Institutional Buying and Selling by Quarter

Arrowhead Pharmaceuticals Major Shareholders & Ownership History

ARWR Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Arrowhead Pharmaceuticals (ARWR) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Arrowhead Pharmaceuticals (NASDAQ:ARWR)

ARWR Institutional Buying and Selling by Quarter

Arrowhead Pharmaceuticals Major Shareholders & Ownership History

ARWR Institutional Ownership - Frequently Asked Questions

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools